Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting.
暂无分享,去创建一个
T. Sterling | A. Pettit | M. Griffin | L. Kaltenbach | J. Warkentin | F. Maruri | J. Cummins | T. Smith
[1] M. Pai,et al. Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] G. Engström,et al. COPD and the Risk of Tuberculosis - A Population-Based Cohort Study , 2010, PloS one.
[3] Philip Supply,et al. Impact of HIV infection on the recurrence of tuberculosis in South India. , 2010, The Journal of infectious diseases.
[4] D. Mitchison,et al. Timing of relapse in short-course chemotherapy trials for tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[5] A. Crampin,et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi , 2010, AIDS.
[6] W. Ray,et al. Use of disease risk scores in pharmacoepidemiologic studies , 2009, Statistical methods in medical research.
[7] J. Vestbo,et al. COPD stage and risk of hospitalization for infectious disease. , 2008, Chest.
[8] W. Ray,et al. Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk Score , 2008, Epidemiology.
[9] B. D. de Jong,et al. Treatment outcomes of patients with HIV and tuberculosis. , 2007, American journal of respiratory and critical care medicine.
[10] C. Leung,et al. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. , 2006, American journal of respiratory and critical care medicine.
[11] Mahboob Rahman,et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. , 2006, Arthritis and rheumatism.
[12] L. Riley,et al. Exogenous reinfection in tuberculosis. , 2005, The Lancet. Infectious diseases.
[13] R. Adegbola,et al. Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. , 2005, International journal of epidemiology.
[14] B. Metchock,et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? , 2004, American journal of respiratory and critical care medicine.
[15] W. Bishai,et al. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] Jasmin Johnson,et al. Factors associated with drug resistance in pulmonary tuberculosis. , 2003, The Indian journal of chest diseases & allied sciences.
[17] R. Chaisson,et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial , 2002, The Lancet.
[18] P. Sonnenberg,et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers , 2001, The Lancet.
[19] J Li,et al. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] C. Locht,et al. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Hayes,et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners , 2000, AIDS.
[22] P. Small,et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. , 2000, Archives of internal medicine.
[23] H. Boshuizen,et al. Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.
[24] J. T. Crawford,et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. , 1997, Archives of internal medicine.
[25] S. Weis,et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. , 1994, The New England journal of medicine.
[26] J. T. Crawford,et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.
[27] R. O'brien,et al. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. , 1990, Annals of internal medicine.
[28] J. T. Crawford,et al. A CONTINUING SURVEY OF DRUG-RESISTANT TUBERCULOSIS , 1997 .